Last 46 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
National HealthCare Corporation's quarterly P/E stands at 12.2x, up 5.5% year-over-year. EV/EBITDA has compressed 31.6% YoY to 11.4x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 22.35 | 12.15 | 17.60 | 11.21 | 68.95 | 11.52 | 15.66 | 13.98 | 12.63 | 23.52 | 14.58 | 19.10 | 36.28 |
| — | +5.5% | +12.4% | -19.8% | +446.1% | -51.0% | +7.4% | -26.8% | -65.2% | — | -88.3% | +7.7% | +117.9% | |
| P/S Ratio | 1.81 | 1.24 | 1.11 | 0.97 | 1.14 | 1.45 | 1.45 | 1.23 | 1.19 | 0.85 | 0.84 | 0.83 | 0.87 |
| — | -14.1% | -23.1% | -21.6% | -4.1% | +70.4% | +72.7% | +49.1% | +37.4% | -5.9% | -16.1% | -18.3% | -11.5% | |
| P/B Ratio | 2.50 | 1.80 | 1.63 | 1.43 | 1.71 | 2.00 | 1.78 | 1.58 | 1.57 | 1.10 | 1.07 | 1.01 | 1.04 |
| — | -9.9% | -8.5% | -9.3% | +9.0% | +80.7% | +66.5% | +56.1% | +51.0% | -0.5% | -10.9% | -15.0% | -9.8% | |
| P/FCF | 17.89 | 8.42 | 7.93 | 10.91 | 90.92 | 49.13 | 9.84 | 99.25 | 20.89 | 9.50 | 7.14 | 30.89 | 36.28 |
| — | -82.9% | -19.4% | -89.0% | +335.3% | +417.0% | +37.9% | +221.3% | -42.4% | — | -52.1% | — | -73.7% | |
| EV / EBITDA | 15.85 | 11.44 | 9.59 | 9.33 | 12.00 | 16.71 | 12.79 | 13.90 | 11.11 | 10.60 | 10.16 | 12.00 | 12.56 |
| — | -31.6% | -25.0% | -32.9% | +7.9% | +57.7% | +25.8% | +15.8% | -11.5% | -43.1% | -48.9% | -3.1% | -12.5% | |
| EV / EBIT | 21.40 | 8.51 | 12.67 | 8.50 | 54.25 | 8.85 | 11.13 | 10.19 | 9.65 | 17.40 | 10.91 | 15.22 | 32.59 |
| — | -3.9% | +13.8% | -16.6% | +462.1% | -49.1% | +2.0% | -33.1% | -70.4% | — | -86.2% | +6.1% | +149.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
National HealthCare Corporation's operating margin was 7.9% in Q3 2025, down 1.2 pp QoQ and up 1.8 pp YoY. Gross margin expanded 4.8% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 37.3% | 39.1% | 39.6% | 39.0% | 36.6% | 37.3% | 38.2% | 38.4% | 38.0% | 36.7% | 38.0% | 37.7% | 36.6% |
| — | +4.8% | +3.7% | +1.5% | -3.8% | +1.6% | +0.5% | +1.7% | +3.8% | +1.7% | +7.1% | +3.7% | -1.7% | |
| Operating Margin | 8.7% | 7.9% | 9.1% | 8.2% | 7.2% | 6.2% | 7.7% | 5.3% | 6.7% | 4.5% | 4.9% | 3.7% | 3.4% |
| — | +28.3% | +17.6% | +56.5% | +7.6% | +37.0% | +56.3% | +41.6% | +95.1% | +199.9% | +194.6% | -29.9% | +0.6% | |
| Net Margin | 8.2% | 10.3% | 6.3% | 8.6% | 1.6% | 12.6% | 9.2% | 8.8% | 9.4% | 3.6% | 5.8% | 4.3% | 2.4% |
| — | -18.5% | -31.4% | -2.3% | -82.6% | +249.3% | +60.0% | +102.8% | +292.3% | +501.5% | +387.6% | -23.8% | -59.1% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.7% | 3.8% | 2.3% | 3.2% | 0.6% | 4.4% | 2.9% | 2.9% | 3.2% | 1.2% | 1.8% | 1.3% | 0.7% |
| — | -14.9% | -18.5% | +13.3% | -80.5% | +277.7% | +55.4% | +113.9% | +337.4% | +530.2% | +422.0% | -20.8% | -58.6% | |
| ROA | — | 2.5% | 1.5% | 2.1% | 0.4% | 2.9% | 2.0% | 2.0% | 2.2% | 0.8% | 1.3% | 0.9% | 0.5% |
| — | -15.1% | -24.5% | +5.2% | -82.0% | +263.7% | +57.9% | +116.0% | +343.4% | +541.6% | +440.5% | -16.8% | -55.9% | |
| ROIC | 8.4% | 2.1% | 2.3% | 2.1% | 1.8% | 1.6% | 1.9% | 1.3% | 1.7% | 1.1% | 1.1% | 0.8% | 0.7% |
| — | +36.4% | +24.1% | +59.4% | +4.5% | +44.2% | +66.4% | +63.1% | +138.5% | +244.8% | +227.5% | -26.4% | -0.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
National HealthCare Corporation's Debt/EBITDA ratio is 3.1x, down from 3.8x last quarter — at a moderate level that warrants monitoring. Debt/Equity has declined for 5 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.12 | 0.17 | 0.20 | 0.22 | 0.23 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 | 0.14 |
| — | -48.4% | +101.3% | +117.5% | +113.0% | +104.9% | -32.2% | -30.8% | -28.5% | -24.5% | -26.8% | -23.6% | -21.8% | |
| Debt / EBITDA | 0.50 | 3.08 | 3.83 | 4.86 | 5.65 | 7.31 | 2.49 | 3.27 | 2.93 | 4.38 | 4.55 | 5.87 | 6.45 |
| — | -57.8% | +53.8% | +48.6% | +93.0% | +66.7% | -45.3% | -44.2% | -54.6% | -52.9% | -56.5% | -11.9% | -25.3% | |
| Current Ratio | — | 1.75 | 1.72 | 1.90 | 1.81 | 1.80 | 2.06 | 2.02 | 1.89 | 1.87 | 1.86 | 1.84 | 1.79 |
| — | -2.8% | -16.5% | -5.9% | -4.6% | -3.8% | +10.7% | +9.7% | +5.9% | +14.0% | +5.9% | +4.0% | +10.3% | |
| Quick Ratio | — | 1.72 | 1.69 | 1.87 | 1.77 | 1.77 | 2.03 | 1.99 | 1.86 | 1.83 | 1.83 | 1.81 | 1.75 |
| — | -2.6% | -16.7% | -6.1% | -4.9% | -3.7% | +11.2% | +10.2% | +6.1% | +14.2% | +5.9% | +4.2% | +10.3% | |
| Interest Coverage | — | 20.86 | — | 14.61 | 11.32 | 12.08 | — | 339.76 | 359.29 | 169.16 | 150.29 | 102.16 | 80.80 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying NHC stock.
National HealthCare Corporation's current P/E is 22.3x. The average P/E over the last 4 quarters is 27.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
National HealthCare Corporation's current operating margin is 8.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking National HealthCare Corporation's business trajectory between earnings reports.